174 related articles for article (PubMed ID: 36367926)
1. Mood stabilizers and risk of all-cause, natural, and suicide mortality in bipolar disorder: A nationwide cohort study.
Chen PH; Tsai SY; Chen PY; Pan CH; Su SS; Chen CC; Kuo CJ
Acta Psychiatr Scand; 2023 Mar; 147(3):234-247. PubMed ID: 36367926
[TBL] [Abstract][Full Text] [Related]
2. Mortality risk and mood stabilizers in bipolar disorder: a propensity-score-weighted population-based cohort study in 2002-2018.
Chan JKN; Wong CSM; Fang CZ; Hung SC; Lo HKY; Chang WC
Epidemiol Psychiatr Sci; 2024 May; 33():e31. PubMed ID: 38779809
[TBL] [Abstract][Full Text] [Related]
3. The rapid suicide protection of mood stabilizers on patients with bipolar disorder: A nationwide observational cohort study in Taiwan.
Tsai CJ; Cheng C; Chou PH; Lin CH; McInnis MG; Chang CL; Lan TH
J Affect Disord; 2016 May; 196():71-7. PubMed ID: 26919054
[TBL] [Abstract][Full Text] [Related]
4. Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study.
Hayes JF; Pitman A; Marston L; Walters K; Geddes JR; King M; Osborn DP
JAMA Psychiatry; 2016 Jun; 73(6):630-7. PubMed ID: 27167638
[TBL] [Abstract][Full Text] [Related]
5. Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder - A nationwide cohort study.
Lintunen J; Lähteenvuo M; Tanskanen A; Tiihonen J; Taipale H
J Affect Disord; 2023 Jul; 333():403-408. PubMed ID: 37084972
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder.
Holm M; Tanskanen A; Lähteenvuo M; Tiihonen J; Taipale H
Eur Neuropsychopharmacol; 2022 Aug; 61():36-42. PubMed ID: 35763976
[TBL] [Abstract][Full Text] [Related]
7. Excess mortality and shortened life expectancy in people with major mental illnesses in Taiwan.
Pan YJ; Yeh LL; Chan HY; Chang CK
Epidemiol Psychiatr Sci; 2020 Aug; 29():e156. PubMed ID: 32792024
[TBL] [Abstract][Full Text] [Related]
8. Lithium, anticonvulsants and suicidal behavior in bipolar disorder.
Yerevanian BI; Koek RJ; Mintz J
J Affect Disord; 2003 Feb; 73(3):223-8. PubMed ID: 12547290
[TBL] [Abstract][Full Text] [Related]
9. Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder.
Song J; Sjölander A; Joas E; Bergen SE; Runeson B; Larsson H; Landén M; Lichtenstein P
Am J Psychiatry; 2017 Aug; 174(8):795-802. PubMed ID: 28595491
[TBL] [Abstract][Full Text] [Related]
10. Mortality and Lithium-Protective Effects after First-Episode Mania Diagnosis in Bipolar Disorder: A Nationwide Retrospective Cohort Study in Taiwan.
Carvalho AF; Hsu CW; Vieta E; Solmi M; Marx W; Berk M; Liang CS; Tseng PT; Wang LJ
Psychother Psychosom; 2024; 93(1):36-45. PubMed ID: 38194936
[TBL] [Abstract][Full Text] [Related]
11. Lipid-modifying agents and risk of all-cause, natural and suicide mortality in schizophrenia: nationwide cohort study.
Chen PH; Tsai SY; Chen PY; Pan CH; Su SS; Chen CC; Kuo CJ
Br J Psychiatry; 2024 May; ():1-9. PubMed ID: 38751180
[TBL] [Abstract][Full Text] [Related]
12. Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: A nationwide registry-based prospective cohort study.
Toffol E; Hätönen T; Tanskanen A; Lönnqvist J; Wahlbeck K; Joffe G; Tiihonen J; Haukka J; Partonen T
J Affect Disord; 2015 Sep; 183():159-65. PubMed ID: 26005778
[TBL] [Abstract][Full Text] [Related]
13. Suicide attempts amongst elderly bipolar patients.
Aizenberg D; Olmer A; Barak Y
J Affect Disord; 2006 Mar; 91(1):91-4. PubMed ID: 16434107
[TBL] [Abstract][Full Text] [Related]
14. Suicide death over the first year of lithium versus valproate treatment in cohorts with and without bipolar disorder.
Smith EG; Austin KL; Kim HM; Miller DR; Sauer BC; Valenstein M
J Psychiatr Res; 2022 Mar; 147():349-356. PubMed ID: 35158303
[TBL] [Abstract][Full Text] [Related]
15. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study.
Crump C; Sundquist K; Winkleby MA; Sundquist J
JAMA Psychiatry; 2013 Sep; 70(9):931-9. PubMed ID: 23863861
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
18. Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide.
Søndergård L; Lopez AG; Andersen PK; Kessing LV
Bipolar Disord; 2008 Feb; 10(1):87-94. PubMed ID: 18199245
[TBL] [Abstract][Full Text] [Related]
19. Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.
Lähteenvuo M; Tanskanen A; Taipale H; Hoti F; Vattulainen P; Vieta E; Tiihonen J
JAMA Psychiatry; 2018 Apr; 75(4):347-355. PubMed ID: 29490359
[TBL] [Abstract][Full Text] [Related]
20. Lithium and suicide prevention in mood disorders and in the general population: A systematic review.
Del Matto L; Muscas M; Murru A; Verdolini N; Anmella G; Fico G; Corponi F; Carvalho AF; Samalin L; Carpiniello B; Fagiolini A; Vieta E; Pacchiarotti I
Neurosci Biobehav Rev; 2020 Sep; 116():142-153. PubMed ID: 32561344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
